Abstract
The design, synthesis and in vitro activities of novel alpha-bromoacryloyl pyrazole, imidazole and benzoheterocyclic derivatives of distamycin A, in which the amidino moiety has been replaced by moieties of different physico-chemical features are described, and the structure-activity relationships are discussed. In spite of the relevance of these modifications on the distamycin frame, these derivatives showed significant growth inhibitory activity against mouse leukemia L1210 cells. Therefore, the presence of the amidino moiety, and in general of a basic moiety, is not an absolute requirement for biological activity of alpha-bromoacrylic derivatives of distamycin.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acids, Heterocyclic / chemical synthesis
-
Acids, Heterocyclic / pharmacology
-
Animals
-
Antibiotics, Antineoplastic / chemical synthesis*
-
Antibiotics, Antineoplastic / pharmacology*
-
Cell Division / drug effects
-
DNA Footprinting
-
DNA, Neoplasm / biosynthesis
-
Deoxyribonuclease I / chemistry
-
Distamycins / chemical synthesis*
-
Distamycins / pharmacology*
-
Doxorubicin / pharmacology
-
Drug Design
-
Drug Screening Assays, Antitumor
-
Indicators and Reagents
-
Leukemia L1210 / drug therapy
-
Leukemia L1210 / pathology
-
Magnetic Resonance Spectroscopy
-
Mice
-
Reverse Transcriptase Polymerase Chain Reaction
-
Tumor Cells, Cultured
Substances
-
Acids, Heterocyclic
-
Antibiotics, Antineoplastic
-
DNA, Neoplasm
-
Distamycins
-
Indicators and Reagents
-
Doxorubicin
-
stallimycin
-
Deoxyribonuclease I